Smartwatch detection of atrial fibrillation after thoracic (lung) surgery
Official title: Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch
Run by Centre Hospitalier Universitaire, Amiens · NCT06724718 · Data updated 2026-11-12
This test sees if a smartwatch's single-lead ECG can find atrial fibrillation early in adults who recently had major thoracic surgery (lobectomy or pneumonectomy).
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 302 (estimated) |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Amiens) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | July 2027 |
| Study ends | December 2027 |
| Registry record updated | June 12, 2025 |
| Trial ID | NCT06724718 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 who had a lobectomy or pneumonectomy with one-lung ventilation within the past 48 hours, are admitted to a conventional surgical unit, can perform a single-lead ECG with a smartwatch, and can give informed consent.
✕Probably not a fit
Patients with a prior history of atrial fibrillation, pacemaker dependency, need for continuous telemetry for AV block or high-rate arrhythmias, those who had other types of thoracic or chest wall surgery, people who are pregnant, or those under legal guardianship are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Postoperative atrial fibrillation occurs in about 20% of patients after thoracic surgery and can lead to stroke, heart failure, myocardial infarction, and higher mortality if not detected early. This interventional protocol enrolls adults who underwent major thoracic surgery with one-lung ventilation within the past 48 hours and are admitted to a conventional surgical unit. Participants will use a smartwatch capable of single-lead ECG recordings for rhythm monitoring while routine postoperative care continues, and smartwatch-detected events will be compared with standard monitoring and clinical diagnosis. Primary outcomes include detection of POAF and timing of detection, with secondary outcomes addressing subsequent interventions and short-term cardiovascular prognosis.
Why it matters
Potential benefit: If successful, the smartwatch approach could enable earlier AF detection after thoracic surgery, allowing faster treatment to reduce stroke and other complications.
How similar studies have gone: Previous outpatient and ambulatory studies have shown single-lead smartwatch ECGs can detect atrial fibrillation, but their use specifically for immediate postoperative detection after thoracic surgery is less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (\>18 years old). * Patients undergoing major thoracic surgery with one-lung ventilation within the past 48 hours. * Scheduled pneumonectomy or lobectomy. * Admission to a conventional surgical unit postoperatively. * Ability to perform single-lead ECG using a smartwatch. * Coverage under a social security system. * Signed informed consent Exclusion Criteria: * History of atrial fibrillation. * Requirement for telemetry for AV block or tachyarrhythmias (\>140 bpm). * Dependency on a pacemaker. * Participation in another interventional clinical trial affecting POAF incidence. * Mediastinal, pleural, or chest wall surgery. * Reoperations or surgeries performed more than 48 hours prior. * Pregnant women. * Patients under guardians or similar legal protection.
Where it's running
-
Centre hospitalier Amiens
Amiens, France Recruiting
Study contacts
- Principal investigator: Pierre Huette, MD — Centre Hospitalier Amiens
- Study coordinator: Pierre Huette, MD
- Email: Huette.pierre@chu-amiens.fr
- Phone: 33322088371
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AirGo Respiratory Monitoring During Lung Resection
Patients undergoing lung resection will wear the AirGo device to continuously monitor breathing before and after surgery to see if it helps track ventilation alongside standard checks.
-
Frailty-focused prehabilitation before heart surgery
This study tests a home-based, frailty-tailored prehabilitation program for adults 65+ waiting 5 weeks or more for heart surgery to see if it improves fitness, frailty, heart-related function, nutrition, inflammation, quality of life, and hospital outcomes.
-
Wireless home prehabilitation for older adults with NSCLC awaiting lung surgery
This study tests whether a personalized home exercise program guided by wearable devices can improve lung function for older NSCLC patients preparing for curative lung surgery.
-
Transdermal buprenorphine patch added to multimodal pain relief after VATS
This study tests whether adding a 5 mcg/hour buprenorphine patch to standard pain relief after unilateral VATS reduces pain in adults.
-
Can short-term atorvastatin around surgery help prevent atrial fibrillation after lung surgery?
This trial tests whether giving a short course of atorvastatin around surgery can reduce new atrial fibrillation after lung resection in adults aged 60 and older.
-
Continuous ESP Block vs Thoracic Epidural for Preventing Chronic Pain After Thoracotomy
This study compares whether a continuous erector spinae plane block can better prevent chronic post-thoracotomy pain than the current standard thoracic epidural analgesia in adults undergoing elective thoracic surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.